(Q94696831)

English

The recombinant humanized anti-IL-6 receptor antibody tocilizumab, an innovative drug for the treatment of rheumatoid arthritis

scientific article published in May 2008

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed ID

18407769

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18407769%20AND%20SRC:MED&resulttype=core&format=json

retrieved

18 May 2020

title

The recombinant humanized anti-IL-6 receptor antibody tocilizumab, an innovative drug for the treatment of rheumatoid arthritis (English)

1 reference

stated in

Europe PubMed Central

PubMed ID

18407769

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18407769%20AND%20SRC:MED&resulttype=core&format=json

18 May 2020

1 reference

1 reference

Yoshiyuki Ohsugi

1

1 reference

stated in

Europe PubMed Central

PubMed ID

18407769

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18407769%20AND%20SRC:MED&resulttype=core&format=json

retrieved

18 May 2020

Tadamitsu Kishimoto

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed ID

18407769

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18407769%20AND%20SRC:MED&resulttype=core&format=json

retrieved

18 May 2020

publication date

1 May 2008

1 reference

stated in

Europe PubMed Central

PubMed ID

18407769

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18407769%20AND%20SRC:MED&resulttype=core&format=json

retrieved

18 May 2020

published in

Expert Opinion on Biological Therapy

1 reference

stated in

Europe PubMed Central

PubMed ID

18407769

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18407769%20AND%20SRC:MED&resulttype=core&format=json

retrieved

18 May 2020

volume

8

1 reference

stated in

Europe PubMed Central

PubMed ID

18407769

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18407769%20AND%20SRC:MED&resulttype=core&format=json

retrieved

18 May 2020

issue

5

1 reference

stated in

Europe PubMed Central

PubMed ID

18407769

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18407769%20AND%20SRC:MED&resulttype=core&format=json

retrieved

18 May 2020

page(s)

669-681

1 reference

stated in

Europe PubMed Central

PubMed ID

18407769

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18407769%20AND%20SRC:MED&resulttype=core&format=json

retrieved

18 May 2020

Identifiers

DOI

10.1517/14712598.8.5.669

1 reference

stated in

Europe PubMed Central

PubMed ID

18407769

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18407769%20AND%20SRC:MED&resulttype=core&format=json

18 May 2020

1 reference

Europe PubMed Central

PubMed ID

18407769

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18407769%20AND%20SRC:MED&resulttype=core&format=json

(Q94696831)

The recombinant humanized anti-IL-6 receptor antibody tocilizumab, an innovative drug for the treatment of rheumatoid arthritis

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)